BrainStorm Receives $800, 000 Non-Dilutive Grant from Israel’s Office of the Chief Scientist

–   BrainStorm Cell Therapeutics Inc. (OTC.QB: BCLI), announced today that Brainstorm Cell Therapeutics Ltd. was awarded a $800, 000 non-dilutive grant from Israel’s Office of the Chief Scientist More...